TVAX Biomedical is a biotechnology company currently performing phase 2b/3 clinical trials to test a unique cancer immunotherapy as a treatment for pediatric brain cancer.
View Top Employees from TVAX Biomedical, Inc.Website | http://tvaxbiomedical.com |
Revenue | $3 million |
Funding | $10.5 million |
Employees | 6 (4 on RocketReach) |
Founded | 2004 |
Address | 10900 S Clay Blair Blvd Ste 700, Olathe, Kansas 66061, US |
Phone | (913) 492-2221 |
Fax | (913) 492-2243 |
Technologies |
JavaScript,
HTML,
PHP
+6 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Clinical Trials, Health Care, Therapeutics |
Competitors | Cytovance Biologics, ORIC Pharmaceuticals Inc., Oxford BioTherapeutics, Paragon Bioservices, Inc., eFFECTOR Therapeutics, Inc. |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54138 Companies, NAICS Code 5413 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular TVAX Biomedical, Inc. employee's phone or email?
The TVAX Biomedical, Inc. annual revenue was $3 million in 2024.
Jean Aguiar is the Head of Clinical Operations of TVAX Biomedical, Inc..
4 people are employed at TVAX Biomedical, Inc..
TVAX Biomedical, Inc. is based in Olathe, Kansas.
The NAICS codes for TVAX Biomedical, Inc. are [54138, 5413, 541, 54].
The SIC codes for TVAX Biomedical, Inc. are [873, 87].